Lindy P. Fox
Dermatology
1701 Divisadero St.
Third And Fourth Floors
San Francisco, CA 94115
Third And Fourth Floors
San Francisco, CA 94115
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 79 publications
Impact of thrombosis on disease progression, cancer and mortality in patients with essential thrombocythemia and polycythemia vera.
Journal: Blood cancer journal
Published: January 30, 2026
Stevens-Johnson syndrome-toxic epidermal necrolysis spectrum reactions to immune checkpoint inhibitor therapy and safety of rechallenge: A retrospective review.
Journal: JAAD case reports
Published: October 13, 2025
Inpatient Management of Hidradenitis Suppurativa: A Delphi Consensus Study.
Journal: Cutis
Published: July 31, 2024
Drug rash with eosinophilia and systemic symptoms to anti-tuberculosis therapy: A retrospective review of inpatients at an academic medical centre in the United States.
Journal: Skin health and disease
Published: April 05, 2024
HIV and mpox: Evaluation of clinical course and outcomes from an international dermatologic registry.
Journal: Journal of the American Academy of Dermatology
Published: September 26, 2023
Severe recurrence of reactive infectious mucocutaneous eruption with extensive ocular involvement in an adult due to SARS-CoV-2.
Journal: JAAD case reports
Published: February 23, 2023
Public health infection prevention: An analysis of existing training during the COVID-19 pandemic.
Journal: Public health
Published: December 24, 2022
The impact of the American Academy of Dermatology/International League of Dermatological Societies COVID-19 Registry during the pandemic: 2500 cases across 72 countries.
Journal: Journal of the American Academy of Dermatology
Published: December 23, 2022
A dermatologic assessment of 101 mpox (monkeypox) cases from 13 countries during the 2022 outbreak: Skin lesion morphology, clinical course, and scarring.
Journal: Journal of the American Academy of Dermatology
Published: November 14, 2022
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management.
Journal: Journal of the American Academy of Dermatology
Published: September 28, 2022
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis.
Journal: Journal of the American Academy of Dermatology
Published: September 28, 2022
The American Academy of Dermatology and International League of Dermatological Societies Monkeypox Registry: Expanding the COVID-19 registry to emerging infections.
Journal: Journal of the American Academy of Dermatology
Published: August 29, 2022
Last Updated: 09/26/2026